0001670747-20-000001.txt : 20200205 0001670747-20-000001.hdr.sgml : 20200205 20200205160110 ACCESSION NUMBER: 0001670747-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BirchBioMed Inc. CENTRAL INDEX KEY: 0001670747 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-260252 FILM NUMBER: 20578709 BUSINESS ADDRESS: STREET 1: 130 KINGSCROSS DRIVE CITY: KING CITY STATE: A6 ZIP: L7B 1E6 BUSINESS PHONE: 866-350-1993 MAIL ADDRESS: STREET 1: 130 KINGSCROSS DRIVE CITY: KING CITY STATE: A6 ZIP: L7B 1E6 D/A 1 primary_doc.xml X0708 D/A LIVE 0001670747 BirchBioMed Inc. 130 KINGSCROSS DRIVE KING CITY A6 ONTARIO, CANADA L7B 1E6 866-350-1993 BRITISH COLUMBIA, CANADA None None Corporation true 2015 Mark S. Miller 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Director Promoter Ryan V. Hartwell 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Director Promoter Susan M. Elliott 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Director Promoter Jon Verbeck 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Biotechnology Decline to Disclose 06b true 0001670747-19-000001 2016-05-20 false true false 100000 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 AZ ARIZONA CA CALIFORNIA FL FLORIDA IN INDIANA MN MINNESOTA NH NEW HAMPSHIRE NY NEW YORK OH OHIO PA PENNSYLVANIA TX TEXAS UT UTAH false 10000000 5302550 4697450 false 97 59200 true 0 true Maxim Group received these fees from prior investments but has waived any commissions or finders fees for this offering going forward. 1719000 true false BirchBioMed Inc. /s/ Mark S. Miller Mark S. Miller Chief Executive Officer 2020-02-03